Akili company info

What does Akili do?
Akili (NASDAQ:AKLI) focuses on developing digital therapeutics to treat cognitive impairments. The company's innovative approach combines scientific research with digital technology to create immersive, therapeutic video games designed to help manage disorders such as ADHD, depression, and autism among others. Akili actively works on expanding its portfolio of treatments, aiming to reach a broader patient population. Its flagship project, a game-based treatment for children with ADHD, showcases the company's commitment to reimagining medicine. By leveraging cutting-edge technology and rigorous scientific methods, Akili strives to improve mental health and cognitive function, making a significant impact on patients' lives around the globe.
Akili company media
Company Snapshot

Is Akili a public or private company?

key
Ownership
Public

How many people does Akili employ?

people
Employees
162

What sector is Akili in?

pie chart
Sector
Health Care

Where is the head office for Akili?

location pin
Head Office
Boston, United States

What year was Akili founded?

founded flag
Year Founded
2011
What does Akili specialise in?
/Digital Medicine /Therapeutic Video Games /Clinical Validation /Neuroscience Research /Patient Care /Prescription Softwares

What are the products and/or services of Akili?

Overview of Akili offerings
EndeavorRx, the first FDA-cleared prescription treatment delivered through a video game for children with ADHD.
AKL-T01, a therapeutic digital treatment designed to improve attention in children with ADHD.
AKL-T02, aimed at treating cognitive impairments in adults with depression.
AKL-T03, an investigational treatment for cognitive dysfunction in patients with multiple sclerosis.
Digital Biomarkers, innovative tools for assessing cognitive and neural health in clinical trials and care.

Who is in the executive team of Akili?

Akili leadership team
  • Dr. Walter Edward Martucci II, Ph.D.
    Dr. Walter Edward Martucci II, Ph.D.
    Co-Founder & Chairman
  • Mr. Matthew  Franklin M.B.A.
    Mr. Matthew Franklin M.B.A.
    President, CEO & Director
  • Dr. Adam  Gazzaley M.D., Ph.D.
    Dr. Adam Gazzaley M.D., Ph.D.
    Co-Founder, Chief Science Advisor & Director
  • Ms. Jacqueline L. Studer J.D.
    Ms. Jacqueline L. Studer J.D.
    Chief Legal Officer, General Counsel & Secretary
  • Ms. Caty  Reid
    Ms. Caty Reid
    VP of Marketing & Communications
  • Dr. Scott H.  Kollins Ph.D.
    Dr. Scott H. Kollins Ph.D.
    Chief Medical Officer
  • Mr. Jonathan  David
    Mr. Jonathan David
    Chief Product Officer